PBS updates

Prasugrel Lupin (Prasugrel)

prasugrel 10 mg tablet, 28 · ORAL · PBS code 14796R

STREAMLINED

What it costs

AU$52.5 PBS-determined price per 28 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2025-05-01.
  • • Repeats: 5.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Acute coronary syndrome (myocardial infarction or unstable angina)


The treatment must be in combination with aspirin; AND

Patient must have percutaneous coronary intervention planned; or

Patient must have previously undergone percutaneous coronary intervention; AND

Patient must not have a known history of either: (i) stroke, (ii) transient ischaemic attack; AND

The treatment must be ceased if a percutaneous coronary intervention is not performed; AND

Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) a nurse practitioner who is continuing treatment with this medicine (of any strength) that was initiated by a medical practitioner as a PBS benefit; AND

Patient must be at least 18 years of age.

Patient must be treated with the recommended maintenance dose of prasugrel according to the TGA-approved Product Information.

Sponsor: Generic Health Pty Ltd ABN 93 110 617 859

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.